Skip to main content
Anna Chalmers
( out of 56 reviews )

Anna Chalmers, MD

Languages spoken: English

Clinical Locations

  • Anna Chalmers, M.D. is an Assistant Professor in Division of Oncology and an investigator at the Huntsman Cancer Institute. Dr. Chalmers is a specialist in adult medical oncology, with a focus in sarcoma. She joined the faculty in 2016 and see patients at the Huntsman Cancer Institute in Salt Lake City and Sugarhouse.

    Dr. Chalmers received her bachelor’s degree from Dartmouth College and her medical degree from Drexel University College of Medicine. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at Rush University Medical Center in Chicago.

    Dr. Chalmers is actively involved in research. She is committed to utilizing clinical studies to benefit her patients at the Huntsman Cancer Institute. She is a member of several international organizations, including the Connective Tissue Oncology Society and the American Society of Clinical Oncology.

    Dr. Chalmers is a native of Newport Beach, California. She enjoys hiking, sailing, and skiing with her children and husband, who is an orthopedic surgeon at the University of Utah.

    Specialties

    Board Certification

    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Patient Rating

    4.9 /5
    ( out of 56 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    April 10, 2024
    HUNTSMAN CANCER CENTER

    Es una experiencia muy buena ya que ella es una Doctora muy profesional en su trabajo siempre preocupada y viendo lo mejor para mi como pasiente.muchas gracias.

    February 23, 2024
    HUNTSMAN CANCER CENTER

    Hannah is intelligently disabled and I liked how Dr. Chalmers included both Hannah and I l, her mother, when speaking about her condition and treatment.

    February 13, 2024
    HUNTSMAN CANCER CENTER

    I didn't get to talk to Dr. Chalmers until after she got out of her meeting but she confirmed everything that Melissa Shepherd and I had talked about earlier.

    February 13, 2024
    HUNTSMAN CANCER CENTER

    Within moments of meeting Dr. Chalmers and her very capable team, I was sure that my unknown cancer future ahead would be an improved and more hopeful one because of their professional and dedicated care.

    February 12, 2024
    HUNTSMAN CANCER CENTER

    Dr. Chalmers always takes the necessary time to answer my questions.

    February 01, 2024
    HUNTSMAN CANCER CENTER

    Superb, knowledgeable Oncologist with empathetic, kind, attentive, responsive manner. She keeps me alive, and, for the most part, having a good quality of life.

    January 27, 2024
    HUNTSMAN CANCER CENTER

    I love Dr. Chalmers. She really does a great job in trying to make sure I am well informed about concerns and treatment options.

    December 21, 2023
    HUNTSMAN CANCER CENTER

    She is absolutely amazing in her care and making sure you understand and like you are family

    November 17, 2023
    HUNTSMAN CANCER CENTER

    Very caring and professional!!!

  • Anna Chalmers, M.D. is an Assistant Professor in Division of Oncology and an investigator at the Huntsman Cancer Institute. Dr. Chalmers is a specialist in adult medical oncology, with a focus in sarcoma. She joined the faculty in 2016 and see patients at the Huntsman Cancer Institute in Salt Lake City and Sugarhouse.

    Dr. Chalmers received her bachelor’s degree from Dartmouth College and her medical degree from Drexel University College of Medicine. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at Rush University Medical Center in Chicago.

    Dr. Chalmers is actively involved in research. She is committed to utilizing clinical studies to benefit her patients at the Huntsman Cancer Institute. She is a member of several international organizations, including the Connective Tissue Oncology Society and the American Society of Clinical Oncology.

    Dr. Chalmers is a native of Newport Beach, California. She enjoys hiking, sailing, and skiing with her children and husband, who is an orthopedic surgeon at the University of Utah.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Oncology
    Board Certification
    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Education history

    Fellowship Hematology and Medical Oncology - Rush University Medical Center Fellow
    Internal Medicine - Rush University Medical Center Resident
    Professional Medical Medicine - Drexel University College of Medicine M.D.
    Dartmouth College B.A.

    Selected Publications

    Journal Article

    1. Puri S, Malani R, Chalmers A, Kerrigan K, Patel SB, Monynahan K, Cannon L, Blouw B, Akerley W (2023). Keeping a track on leptomeningeal disease in non-small cell lung cancer: A single-institution experience with CNSide(TM). Neurooncol Adv, 6(1), vdad150. (Read full article)
    2. Kerrigan K, Patel SB, Haaland B, Ose D, Weinberg Chalmers A, Haydell T, Meropol NJ, Akerley W (2020). Prognostic Significance of Patient-Reported Outcomes in Cancer. JCO Oncol Pract, 16(4), e313-e323. (Read full article)
    3. Chalmers AW, Patel S, Boucher K, Cannon L, Esplin M, Luckart J, Graves N, Van Duren T, Akerley W (2019). Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up. Target Oncol, 14(4), 417-421. (Read full article)
    4. Chalmers A, Cannon L, Akerley W (2018). Adverse Event Management in Patients with BRAF V600E-Mutant Non-Small Cell Lung Cancer Treated with Dabrafenib plus Trametinib. Oncologist, 24(7), 963-972. (Read full article)

    Editorial

    1. Chalmers AW, Patel SB, Akerley W (2018). Immunotherapy after chemoradiotherapy in stage III non-small cell lung cancer: a new standard of care? J Thorac Dis, 10(3), 1198-1200. (Read full article)

    Letter

    1. Chalmers A, Akerley W (2017). Retrospective, Multi-Institutional Analysis of Sequential Treatment of Brain Metastases in Treatment-Naïve, Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer Should Not Define the Standard of Practice. [Letter to the editor]. J Clin Oncol, 35(20), 2340. (Read full article)